Griffin DR - Search Results

1

Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients.

Dworkin RH, Boon RJ, Griffin DR, Phung D. Dworkin RH, et al. Among authors: griffin dr. J Infect Dis. 1998 Nov;178 Suppl 1:S76-80. doi: 10.1086/514260. J Infect Dis. 1998. PMID: 9852980 Clinical Trial.

2

Acute pain in herpes zoster: the famciclovir database project.

Dworkin RH, Nagasako EM, Johnson RW, Griffin DRJ. Dworkin RH, et al. Pain. 2001 Oct;94(1):113-119. doi: 10.1016/S0304-3959(01)00347-5. Pain. 2001. PMID: 11576750

3

Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia.

Nagasako EM, Johnson RW, Griffin DR, Dworkin RH. Nagasako EM, et al. Among authors: griffin dr. J Am Acad Dermatol. 2002 Jun;46(6):834-9. doi: 10.1067/mjd.2002.120924. J Am Acad Dermatol. 2002. PMID: 12063479

4

Risk factors for postherpetic neuralgia in patients with herpes zoster.

Jung BF, Johnson RW, Griffin DR, Dworkin RH. Jung BF, et al. Among authors: griffin dr. Neurology. 2004 May 11;62(9):1545-51. doi: 10.1212/01.wnl.0000123261.00004.29. Neurology. 2004. PMID: 15136679 Clinical Trial.

5

Efficacy of famciclovir in the treatment of herpes zoster: reduction of pain associated with zoster.

Boon RJ, Griffin DR. Boon RJ, et al. Among authors: griffin dr. Neurology. 1995 Dec;45(12 Suppl 8):S76-7. doi: 10.1212/wnl.45.12_suppl_8.s76. Neurology. 1995. PMID: 8545031 Review. No abstract available.

6

Famciclovir: efficacy in zoster and issues in the assessment of pain.

Boon RJ, Griffin DR. Boon RJ, et al. Among authors: griffin dr. Adv Exp Med Biol. 1996;394:17-31. doi: 10.1007/978-1-4757-9209-6_3. Adv Exp Med Biol. 1996. PMID: 8815684 Review. No abstract available.

7

Geographic and racial aspects of herpes zoster.

Nagasako EM, Johnson RW, Griffin DR, Elpern DJ, Dworkin RH. Nagasako EM, et al. Among authors: griffin dr. J Med Virol. 2003;70 Suppl 1:S20-3. doi: 10.1002/jmv.10315. J Med Virol. 2003. PMID: 12627482

8

Conjugation of IL-33 to Microporous Annealed Particle Scaffolds Enhances Type 2-Like Immune Responses In Vitro and In Vivo.

Roosa CA, Lempke SL, Hannan RT, Nicklow E, Sturek JM, Ewald SE, Griffin DR. Roosa CA, et al. Among authors: griffin dr. Adv Healthc Mater. 2024 Apr 22:e2400249. doi: 10.1002/adhm.202400249. Online ahead of print. Adv Healthc Mater. 2024. PMID: 38648258

9

Anterior knee pain patients without structural knee abnormalities and normal lower limb skeletal alignment have a higher prevalence of cam-femoroacetabular impingement syndrome than the general population.

Tey-Pons M, Sanchis-Alfonso V, Parra-Calabuig L, Griffin DR, Espregueira-Mendes J, Monllau JC. Tey-Pons M, et al. Among authors: griffin dr. J ISAKOS. 2024 Mar 14:S2059-7754(24)00051-8. doi: 10.1016/j.jisako.2024.03.006. Online ahead of print. J ISAKOS. 2024. PMID: 38490438 Free article.

10

Microporous Annealed Particle (MAP) Scaffold Pore Size Influences Mesenchymal Stem Cell Metabolism and Proliferation Without Changing CD73, CD90, and CD105 Expression Over Two Weeks.

Pfaff BN, Flanagan CC, Griffin DR. Pfaff BN, et al. Among authors: griffin dr. Adv Biol (Weinh). 2024 Feb;8(2):e2300482. doi: 10.1002/adbi.202300482. Epub 2023 Nov 13. Adv Biol (Weinh). 2024. PMID: 37955859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page